Add to ORKGThe impaired bone anabolic effect of PTH in the absence of endogenous FGF2 is partially due to reduced ATF4 expressio
Parathyroid hormone (PTH) increases fibroblast growth factor receptor-1 (FGFR1) and fibroblast growt...
The mechanisms of the anabolic effect of parathyroid hormone (PTH) in bone are not fully defined. Th...
Although the capacity of exogenous PTH1-34 to enhance the rate of bone repair is well established in...
Parathyroid hormone (PTH) is currently the only approved anabolic agent for osteoporosis pharmacothe...
Parathyroid hormone (PTH) is currently the only approved anabolic agent for osteoporosis pharmacothe...
Parathyroid hormone (PTH) is currently the only approved anabolic agent for osteoporosis pharmacothe...
Parathyroid hormone (PTH) is currently the only approved anabolic agent for osteoporosis pharmacothe...
Parathyroid hormone (PTH) is currently the only approved anabolic agent for osteoporosis pharmacothe...
Parathyroid hormone (PTH) is a potent anabolic agent for the treatment of osteoporosis. However, its...
Parathyroid hormone (PTH) is a potent anabolic agent for the treatment of osteoporosis. However, its...
Parathyroid hormone (PTH) is a potent anabolic agent for the treatment of osteoporosis. However, its...
Parathyroid hormone (PTH) is a potent anabolic agent for the treatment of osteoporosis. However, its...
Since parathyroid hormone (PTH) increased FGF2 mRNA and protein expression in osteoblasts, and serum...
Our previous studies showed that fibroblast growth factor 2 (FGF2) intermittent treatment stimulates...
Our previous studies showed that fibroblast growth factor 2 (FGF2) intermittent treatment stimulates...
Parathyroid hormone (PTH) increases fibroblast growth factor receptor-1 (FGFR1) and fibroblast growt...
The mechanisms of the anabolic effect of parathyroid hormone (PTH) in bone are not fully defined. Th...
Although the capacity of exogenous PTH1-34 to enhance the rate of bone repair is well established in...
Parathyroid hormone (PTH) is currently the only approved anabolic agent for osteoporosis pharmacothe...
Parathyroid hormone (PTH) is currently the only approved anabolic agent for osteoporosis pharmacothe...
Parathyroid hormone (PTH) is currently the only approved anabolic agent for osteoporosis pharmacothe...
Parathyroid hormone (PTH) is currently the only approved anabolic agent for osteoporosis pharmacothe...
Parathyroid hormone (PTH) is currently the only approved anabolic agent for osteoporosis pharmacothe...
Parathyroid hormone (PTH) is a potent anabolic agent for the treatment of osteoporosis. However, its...
Parathyroid hormone (PTH) is a potent anabolic agent for the treatment of osteoporosis. However, its...
Parathyroid hormone (PTH) is a potent anabolic agent for the treatment of osteoporosis. However, its...
Parathyroid hormone (PTH) is a potent anabolic agent for the treatment of osteoporosis. However, its...
Since parathyroid hormone (PTH) increased FGF2 mRNA and protein expression in osteoblasts, and serum...
Our previous studies showed that fibroblast growth factor 2 (FGF2) intermittent treatment stimulates...
Our previous studies showed that fibroblast growth factor 2 (FGF2) intermittent treatment stimulates...
Parathyroid hormone (PTH) increases fibroblast growth factor receptor-1 (FGFR1) and fibroblast growt...
The mechanisms of the anabolic effect of parathyroid hormone (PTH) in bone are not fully defined. Th...
Although the capacity of exogenous PTH1-34 to enhance the rate of bone repair is well established in...